Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII)

Special purpose acquisition company

Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII) is listed on Nasdaq, where it has traded since December 3, 2025.

Type
Special purpose acquisition company
Listed On
Nasdaq
Listed Since
December 3, 2025
Employees
2
Market Cap
$649M

About Drugs Made In America Acquisition II Corp. Ordinary Shares

Drugs Made In America Acquisition II Corp is a blank check Company.

Institutional ownership

In 13F filings for the quarter ended June 30, 2026, 66 institutions reported holding DMII, with 44.6 million shares worth $448.7 million in aggregate. The largest reported holder was Karpus Management, with 2.8 million shares worth $28.0 million. Of the 5 largest holders listed below, 2 added shares, 1 reduced its position and 2 held their positions unchanged during the quarter.

InstitutionSharesValueQuarter change
Karpus Management2,787,998$28MAdded 7.32%
Mmcap International Inc. Spc2,700,000$27MUnchanged
Magnetar Financial2,700,000$27MUnchanged
Glazer Capital2,343,278$24MReduced 0.28%
Highbridge Capital Management2,241,215$23MAdded 896.08%

Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.

Frequently asked questions

What is DMII?

Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII) is listed on Nasdaq, where it has traded since December 3, 2025.

Who are the largest institutional holders of DMII?

In 13F filings for the quarter ended June 30, 2026, the largest reported holders of DMII were Karpus Management, Mmcap International Inc. Spc and Magnetar Financial.

How many institutions own DMII?

66 institutions reported a position in DMII for the quarter ended June 30, 2026, worth $448.7 million in total.

Did institutions buy or sell DMII last quarter?

Of the 5 largest reported holders, 2 added shares, 1 reduced its position and 2 held their positions unchanged during the quarter. Every reported holder and its change is on the SentiSense ownership page for DMII.

Every reported institutional holder, plus insider and congressional trades in DMII, on SentiSense.